Functions of the 5' leader of murine leukemia virus genomic RNA in virion structure, viral replication and pathogenesis, and MLV-derived vectors

Biochimie

Volumn 78, Issue 7, 1996, Pages 632-638

  Corbin, A ^a   Darlix, J L ^a  

^a CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

Author keywords

MuLV; Pathogenesis; Recombination; Retroviral vector; Retrovirus; Reverse Transcription; Translation

Indexed keywords

VIRUS VECTOR;

ARTICLE; GENE THERAPY; GENE TRANSFER; LEUKEMIA VIRUS; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PATHOGENESIS; RETROVIRUS; RNA STRUCTURE; VIRION; VIRUS REPLICATION;

ANIMALIA; MURINAE; MURINE LEUKEMIA VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0029914785     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(96)80009-5     Document Type: Article

References (47)

1. Teich N. Taxonomy of Retroviruses. Weiss R, Teich N, Varmus H, Coffin J. 2nd edn RNA Tumor Viruses. 1985;25-207 Cold Spring Harbor Laboratory, Cold Spring Harbor, New-York.
2. Coffin J. Genome structure. Weiss R, Teich N, Varmus H, Coffin J. 2nd edn RNA Tumor Viruses. 1985;17-74 Cold Spring Harbor Laboratory, Cold Spring Harbor, New-York. part 2.
3. Darlix JL, Lapadat-Tapolsky M, de Rocquigny H, Roques B. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. Review article J Mol Biol. 254:1995;523-537.
4. Varmus H, Swanstrom R. Replication of retroviruses. Weiss R, Teich N, Varmus H, Coffin J. 2nd edn RNA Tumor Viruses. 1985;369-512 Cold Spring Harbor Laboratory, Cold Spring Harbor, New-York.
5. Hu WS, Temin H. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci USA. 87:1990;1556-1560.
6. Teich N, Wyke J, Mak T, Bernstein A, Hardy W. Pathogenesis of retrovirus-induced disease. Weiss R, Teich N, Varmus H, Coffin J. 2nd edn RNA Tumor Viruses. 1985;856-923 Cold Spring Harbor Laboratory, Cold Spring Harbor, New-York.
7. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA. 85:1988;6440-6464.
8. Miller AD, Garcia JV, von Suhr N, Lynch CM, Wilson C, Eiden MV. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol. 65:1991;220-2224.
9. Mehtali M. Des virus pour greffer des gènes. La Recherche. 25:1994;1116-1121.
10. Berlioz C, Darlix JL. An internal ribosomal entry mechanism promotes translation of MuLV gag polyprotein precursors. J Virol. 69:1995;2214-2222.
11. Tounekti N, Mougel M, Roy C, Marquet R, Darlix JL, Paoletti J, Ehresmann B, Ehresmann C. Effect of dimerization on the conformation of the encapsidation Psi domain of Moloney murine leukemia virus RNA. J Mol Biol. 223:1992;205-220.
12. Corbin A, Prats AC, Darlix JL, Sitbon M. A non structural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses. J Virol. 68:1994;3857-3867.
13. Wang H, Kavanaugh MP, North RA, Kabat D. Cell surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature. 352:1991;729.
14. Katz R, Skalka AM. The retroviral enzymes. Annu Rev Biochem. 63:1994;133-173.
15. Roe T, Reynolds T, Yu G, Brown P. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:1993;2099-2108.
16. Luciw PA, Leung NJ. Mechanisms of Retrovirus Replication. Levy JA. The Retroviridae. 1:1992;215-229 Plenum Press, New York, USA.
17. Wills J, Craven R. From, function, and use of retroviral gag proteins. AIDS. 5:1991;639-654.
18. Luciw PA, Leung NJ. Mechanisms of Retrovirus Replication. Levy JA. The Retroviridae. 1:1992;246-250 Plenum Press, New York, USA.
19. Prats A, Roy C, Wang P, Roy C, Paoletti C, Darlix JL. Cis elements and trans-acting factors involved in dimer formation of MuLV RNA. J Virol. 64:1990;774-783.
20. Sitbon M, Sola B, Evans L, Nishio J, Hayes SF, Nathanson K, Garon CF, Chesebro B. Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV; Mapping of the effects to different regions of the viral genome. Cell. 47:1986;851-859.
21. Portis JL. Wild mouse retrovirus pathogenesis. Curr Top Microbiol Immunol. 160:1990;11-27.
22. Li Y, Golemis E, Hartley JW, Hopkins N. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides. J Virol. 61:1987;693-700.
23. DesGroseillers L, Barrette M, Jolicoeur P. Physical mapping of the paralysis-inducing determinant of a wild mouse ecotropic neurotropic virus. J Virol. 52:1984;356-363.
24. Sitbon M, d'Auriol L, Ellerbrok H, Andre C, Nishio J, Perryman S, Pozo F, Hayes SF, Wehrly K, Tambourin P, Galibert F, Chesebro B. Substitution of leucine for isoleucine in a sequence highly conserved among retroviral envelope surface glycoproteins attenuates the lytic effect of the Friend murine leukemia virus. Proc Natl Acad Sci USA. 88:1991;5932-5936.
25. Sitbon M, Ellerbrok H, Pozo F, Nishio J, Hayes SF, Evans LH, Chesebro B. Sequences in the U5-gag-pol influence early and late pathogenic effects of Friend and Moloney murine leukemia viruses. J Virol. 64:1990;2135-2140.
26. Richardson J, Corbin A, Pozo F, Orsoni S, Sitbon M. Sequences responsible for the distinctive hemolytic potentials of Friend and Moloney murine leukemia viruses are dispersed but confined to the Psi-gag-PR region. J Virol. 67:1993;5478-5486.
27. Fan H, Chite H, Chao E, Feuerman M. Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein. Proc Natl Acad Sci USA. 80:1983;5965-5969.
28. Schwartzberg P, Colicelli J, Goff SP. Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent. J Virol. 46:1983;538-546.
29. Portis JL, Czub S, Garon CF, McAtee FJ. Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from non-defective friend murine leukemia virus. J Virol. 64:1990;1648-1656.
30. Portis JL, Perryman S, McAtee FJ. The R-U5-5′ leader sequence of neurovirulent wild mouse retrovirus contains an element controlling the incubation period of neurodegenerative disease. J Virol. 65:1991;1877-1883.
31. Czub M, McAtee FJ, Portis JL. Murine retrovirus-induced spongiform encephalomyelopathy: Host and viral factors which determine the length of the incubation period. J Virol. 66:1992;3298-3305.
32. Portis JL, Spangrude GJ, McAtee FJ. Identification of a sequence in the unique 5′ open reading frame of the gene encoding glycosylated gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus. J Virol. 68:1994;3879-3887.
33. Czub M, Czub S, McAtee FJ, Portis JL. Age-dependent resistance to murine retrovirus-induced spongiform neurodegeneration results from central nervous system-specific restriction of virus replication. J Virol. 65:1991;2539-2544.
34. Friedmann T. Progress toward human gene therapy. Science. 244:1989;1275-1281.
35. Berberich SL, Stolztfus M. Mutations in the region of RSV 3′ splice sites: implications for regulation of alternative splicing. J Virol. 65:1991;2640-2646.
36. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques. 9:1989;980-990.
37. Emerman M, Temin HM. High frequency deletion in recovered retrovirus vectors containing exogenous DNA with promoters. J Virol. 50:1984;42-49.
38. Pelletier J, Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature. 334:1988;320-325.
39. Ghattas I, Sanes J, Majors J. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol Cell Biol. 11:1991;5848-5859.
40. Torrent C, Berlioz C, Darlix JL. Stable MLV-VL30 dicistronic retroviral vectors with a VL30 or MoMLV sequence promoting both packaging of genomic RNA and expression of the 3′ cistron. Human Gene Therapy. 7:1996;603-612.
41. Mountford P, Smith A. Internal ribosome entry sites and dicistronic RNAs in mammalian transgenesis. TIGS. 11:1995;179-184.
42. Chowdury JR, Grossman M, Gupta S, Chowdhury NR, Baker JR, Wilson JM. Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDR-deficient rabbits. Science. 254:1991;1802-1805.
43. Ferry N, Duplessis O, Houssin D, Danos O, Heard JM. Retroviral-mediated gene transfer into hepatocytes in vivo. Proc Natl Acad Sci USA. 88:1991;8377-8381.
44. Temin H. Safety considerations in somatic gene therapy of human disease with retrovirus vectors. Human Gene Therapy. 1:1990;111-123.
45. Coffin J. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science. 267:1995;483-489.
46. Fu W, Rein A. Maturation of dimeric viral RNA of MoMuLV. J Virol. 67:1993;5443-5449.
47. Darlix JL, Bromley P, Spahr PF. Analysis of RSV RNA structure by means of specific nucleases. Virology. 90:1978;317-329.